SCHEMBL526363

SCHEMBL526363

N#Cc1cccc(Oc2cccc([C]=O)c2Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 8/20 0.55
VEGFA P15692 3/20 0.42
CYP19A1 P11511 1/20 0.41
AR P10275 4/20 0.41
SLC22A12 Q96S37 1/20 0.40
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
PGGT1B P53609 1/20 0.40
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
ERBB3 P21860 1/20 0.38
ERBB4 Q15303 1/20 0.38
STK10 O94804 1/20 0.37
SLK Q9H2G2 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8432193 0.78 AR (0.55) EPAS1VEGFACYP19A1ARSLC22A12
SCHEMBL920869 0.77 AR (0.54) EPAS1VEGFACYP19A1ARFNTA
SCHEMBL4168817 0.74 POLB (0.50) CYP19A1ARPDE4APDE4BPDE4C
SCHEMBL8379001 0.74 PDE4A (0.54) EPAS1VEGFACYP19A1ARPDE4A
SCHEMBL27839327 0.72 PDE4A (0.53) EPAS1VEGFACYP19A1ARPDE4A
SCHEMBL8432101 0.72 AR (0.49) EPAS1VEGFACYP19A1ARFNTA
SCHEMBL921055 0.72 CYP19A1 (0.56) EPAS1CYP19A1ARPDE4APDE4B
SCHEMBL16555761 0.71 EPAS1 (1.00) EPAS1VEGFA
SCHEMBL890666 0.71 GAA (0.58) EPAS1VEGFACYP19A1ARFNTA
SCHEMBL922800 0.71 EPAS1 (0.47) EPAS1VEGFACYP19A1ARSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO disclosed